I lost 6st on Mounjaro - this is what I've done to keep the weight off
Ellen Ogley, a 42 year old mother of three, tipped the scales at 16st 12lbs, wearing size 18 clothing at her heaviest point.
After losing three stone on what she described as an "unsustainable diet" and achieving a "quick fix" tummy tuck, Ellen was still not satisfied with her appearance.
Read more: Entire cabin crew suspended
It was the discovery of Mounjaro that truly made a difference, quelling her incessant craving for snacks and addressing her "food noise".
The Yorkshire-based nursery manager has since regulated her weight to an impressive 10st to 10st 3lbs, slipping into a size six attire, a change she has sustained for over half a year.
What's been crucial for her progress? She swapped frequent takeaways and heavy-drinking weekends for home-made 'fakeaways' and consistent weight training - a swap that has left her feeling "amazing".
Hailing from Ilkley, Ellen stated: "I wanted to make sure I wasn't reliant on Mounjaro."
Using the medication as a temporary aid, she reflected: "I used this as a tool."
Her commitment went beyond just dietary changes, as she emphasized: "I've done so much work on damage limitation."
With her transformation, Ellen aims to inspire others with the assurance that keeping the weight off is achievable, declaring: "I want to give others hope they can keep it off.
"I feel incredible," she enthused about her current state of well-being.
Ellen confesses that she resorted to "comfort eating" during a troubling time marked by illness, which escalated until she received a dual diagnosis of cervical and ovarian cancer.
In retrospect, she laid bare her unhealthy coping mechanisms: "I had blow outs and would have takeaways and binge drinking - it was a coping mechanism."
Admitting to her prior excessive indulgences, she shared: "I'd have two to three takeaways a week. My drinking was excessive."
She recalled the times when she and her husband would go through "My husband and I would have three bottles of wine between us - it helped numb everything."
Ellen underwent a necessary hysterectomy and was warned about elevated risks associated with her BMI, which peaked at 36.5. She made a promise to herself: "I said to myself 'if I come out the other side I will try and take control of my health'."
Post-recovery in September 2023, Ellen decided to lose weight but craved a "quick fix". In her own words: "I was looking for an easy way out."
She even consulted a surgeon hoping a cosmetic procedure would deliver fast results: "I went to see a surgeon for a tummy tuck."
Yet to qualify for both a tummy tuck and liposuction, she had a goal to shed three stone: "But I needed to lose three stone in order to have a tummy tuck and liposuction to get skinny."
Ellen embarked on intermittent fasting and stringent dieting, slimming down to 13st 10lbs, although she admits: "I was doing it in not a very healthy way."
The weight loss path wasn't without its challenges, as Ellen conceded: "I was almost starving myself."
Furthermore, she realized that such measures were far from a viable long-term plan: "It was not sustainable."
By February 2024, she completed a £10k tummy tuck, content with the outcomes but still desiring further weight decrease: "I only lost 4lbs more after the tummy tuck."
Her disappointment soon led to a preoccupation with her appearance: "I was devastated."
She struggled with her self-perception, particularly regarding her arms: "I became obsessed with my body - pulling at it."
Eventually, Ellen turned to weight loss medication, starting Mounjaro in May 2024 and combining it with cardiovascular training: "I thought it was going to be another diet trend but the food noises got switched off."
She noticed significant changes in her eating habits: "Before I would raid the cupboard when my husband took his daughter to gymnastics."
Inspiringly, once on the medication, she experienced a remarkable shift: "As soon as I went on I realised 'I've not touched the snack cupboard'."
This marked the beginning of improved lifestyle decisions: "I started making better lifestyle choices."
Ellen was on the jab for just 22 weeks, easing herself off gradually, but found herself fixated on getting as "skinny as possible".
She revealed: "I lost my focus."
She also shared her ordeal with online abuse: "I got trolled - they called me Skeletor, I was being told I looked like a 60-year-old."
It wasn't until her husband, Phil Ogley, 53, a surveyor, commented that she looked unwell that Ellen realised she needed to change, leading her to embrace weight training.
Now feeling "healthy and strong", Ellen has sustained her weight loss without relying on micro-dosing Mounjaro.
She expressed her successful strategy: "I've been learning how to fuel my body."
She's developed useful tricks: "I have hacks in place - if I'm craving sweets I have Greek yoghurt, berries and granola."
Ellen still indulges in the occasional takeaway, but practices portion control.
They've swapped out regular takeaways for homemade versions: "We make chicken kebabs as fakeaways instead of ordering them as takeaways."
The results astound her: "I have abs at 42 - it blows my mind."
Previously, her diet lacked structure with no breakfast, a jacket potato, cheese and beans for lunch, and a dinner of pasta bake followed by apple pie and custard. Snacking included a packet of biscuits and cookies.
Her current diet is more balanced: she starts her day with Greek yoghurt, berries, granola or overnight oats; lunch is a chicken salad; and dinner alternates between chicken with sweet potato fries and tortilla wrap pizzas.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Epoch Times
10 hours ago
- Epoch Times
FDA Advises Americans Against ‘Mousse' Sunscreens, Warns 5 Manufacturers
Americans should 'beware' of sunscreen products in mousse form as they may not be effective, the Food and Drug Administration (FDA) said in an Aug. 12 X post, with the agency sending warning letters to five companies marketing sunscreen products. The letters were sent on Aug. 6 to Texas-based Supergoop, Pennsylvania-based Fallien Cosmeceuticals Ltd., Israel-based K & Care Organics, Sweden-based Kalani AB, and Florida-based Vacation Inc.


Los Angeles Times
13 hours ago
- Los Angeles Times
Unlocking Cellular Health With Science and Trust
In the longevity and wellness space, Niagen Bioscience is charting a course defined by both scientific rigor and an unwavering commitment to responsible innovation Niagen Bioscience (NASDAQ: NAGE, formerly Chromadex) is a Los Angeles-based company dedicated to advancing the supplements industry using science-backed research into their component ingredients. At the helm is CEO Robert Fried, who says the company's mission is to pioneer NAD+ research and develop transformative NAD-boosting healthy-aging solutions with Niagen, their patented form of nicotinamide riboside (NR). Niagen is the cornerstone of the company's clinically proven product portfolio, Tru Niagen and Niagen IV and injections. During this year's Cannes Lions, Fried sat down with LA Times Studios to discuss how the company is pioneering the NAD+ space and the science and quality backed benefits of its Niagen products. 'NAD+, or nicotinamide adenine dinucleotide, is a co-enzyme found in all living cells – plant and animal – and is involved in all important metabolic processes within the cell, but especially energy metabolism and DNA repair, which are key to supporting mitochondrial health and overall optimal health.' explained Fried. Mitochondria, the 'battery pack of the cell,' combines nutrients from the food you eat and oxygen with NAD+ to produce energy. NAD+ also plays a crucial role in DNA recovery and cellular repair. 'All of these processes that exist within the cell where the cell repairs damage are NAD+ dependent,' Fried emphasized, illustrating how higher NAD+ levels facilitate rapid healing, contrasting youthful recovery with a slower healing process that occurs as we age. This is because NAD+ starts to decline naturally in our 30s, with research showing a dramatic drop of up to 65% by the time we reach age 70. Exposure to stressors like sedentary lifestyle, excess sun exposure, poor diet and environmental factors also impact NAD+ levels. Research shows that NAD+ decline is associated with a decline in overall health and vitality, contributing to the development of conditions and disease. Fried is quick to address a significant industry misconception: 'NAD+ itself is not bioavailable. If you consume NAD+ orally or with an IV, it will not elevate NAD+ levels inside your cells.' He clarified that the NAD+ molecule is too large to penetrate cells, causing NAD+ supplements and IV to be ineffective. Intact NAD+ may even have the potential to cause acute immune inflammatory response, which may be responsible for the uncomfortable side effects associated with NAD+ IV and injections. The solution, according to Fried, is 'to consume an NAD+ precursor molecule that easily gets into the cell and then converts into NAD+, and the best molecule for this is called nicotinamide riboside or NR.' Niagen is patented NR and precisely what Tru Niagen and pharmaceutical-grade Niagen IV and injections offer. With a legacy spanning over 25 years, the company's recent rebranding from ChromaDex to Niagen Bioscience reflects its sharpened focus. 'We're no longer only a reference standards company but an NAD+ company dedicated to addressing one of life's most complex challenges - aging,' said Fried. Niagen Bioscience differentiates itself by operating as an 'R&D lab that specializes in NAD+,' not simply a supplement distributor, he said. Its distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and an external research program helping independent investigators and institutions worldwide uncover the potential of NAD+. 'There is no other company in the supplement space that comes close this level of R&D investment and scientific research,' Fried asserted. The company boasts 38 peer-reviewed, published human clinical studies on oral food-grade Niagen, of which about 95% are completely independent, with another 40 studies currently underway. This level of scientific rigor, he contends, is typically found only in biotech or pharmaceutical companies. Products are tested at the manufacturing facility and then retested upon delivery. Fried notes their marketing: 'We are real. We are genuine. We let the science do the talking.' This approach, he believes, is key to building genuine trust. Niagen Bioscience is exploring Niagen's broader therapeutic potential for its patented NR. Fried reveals extensive clinical studies on the benefits of its patented food-grade NR for specific age-related and orphan diseases (rare conditions characterized by rapid aging). Some of these studies have reached Phase II and III clinical trials. A 52 week, 400-participant, Phase III double-blinded, controlled study on Parkinson's disease recently concluded, conducted with a world-renowned independent researcher. 'That is a level of scientific research ... that you don't see from supplement companies,' Fried emphasized. Niagen Bioscience is also innovating beyond oral supplements. They've developed a pharmaceutical-grade version of nicotinamide riboside, now available as Niagen IV. exclusively at clinics across the U.S. Fried highlighted its advantages: 'If you do an injection or an IV, you're getting the benefits of Niagen directly to the bloodstream.' This results in faster absorption and avoids side effects often associated with direct NAD+ infusions. Fried candidly addresses his concern about a lack of public trust in the dietary supplement industry, citing prevalent unsubstantiated claims, low-quality products, and marketing hype. 'It's my belief that if people genuinely trusted the companies that the industry at large would be so significant because we'd actually have preventative health value,' he states. To combat this, Niagen Bioscience has proposed a 'Trust Alliance' – a coalition of industry players, government and non-profits to test products and ensure claims are met. For Fried, the most meaningful aspect of his journey is receiving letters from individuals who experienced health benefits after taking Tru Niagen. Looking ahead, Niagen Bioscience aims to solidify its position as the 'gold standard in the NAD+ space,' continuing its scientific leadership. 'Our mission is to help every living being around the world age better. We think what could happen in the next five years is very exciting and special,' Fried concluded.

Epoch Times
a day ago
- Epoch Times
Malfunctioning Insulin Pumps Recalled After 59 Injuries
San Diego-based Tandem Diabetes Care, Inc. is voluntarily recalling insulin pumps used to manage blood sugar, the company said in an Aug. 12 announcement by the Food and Drug Administration. Insulin pumps are wearable devices that deliver insulin at predetermined doses at specific times. Such devices can feature alarm functions to alert users about various situations, such as issues with insulin delivery.